Bausch Health reports strong Q4 earnings beat and bullish outlook, stock pops after hours.

From StockTwits: 2025-02-19 22:12:15

Bausch Health Companies Inc. saw a 34% increase in Q4 revenue, reaching $2.56 billion, beating estimates. Adjusted earnings per share came in at $1.14, slightly above expectations. CEO Thomas Appio praised 2024 as a year of meeting commitments, with strong results. Salix division generated $634 million in revenue, up 9%, driven by Xifaxan’s growth. Solta segment revenue surged 34% to $138 million, led by demand in South Korea and China. For 2025, Bausch Health projects revenue of $9.90-$10.15 billion and adjusted EBITDA of $3.525-$3.675 billion. Stocktwits sentiment turned ‘extremely bullish’ post-earnings, with message volume spiking 1,900%.



Read more at StockTwits: Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises